HomeBUSINESS
BUSINESS

Aspen Taking Over Anexate from Astellas
(Nov.7.2018)

Aspen Japan said on November 6 that it will take over the marketing authorization for the benzodiazepine receptor antagonist Anexate (flumazenil) from Astellas Pharma ...
(LOG IN FOR FULL STORY)